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AbstrACt
Objectives Immunisations against influenza and 
Bordetella pertussis infection are recommended to 
pregnant women in Valencia (Spain), yet vaccination rates 
remain low. Health literacy (HL) appears as a crucial factor 
in vaccination decision-making. We explored the relation 
between HL of pregnant women and decisions to receive 
influenza and pertussis immunisations.
setting University hospital in Valencia (Spain).
Participants 119 women who gave birth at a hospital 
in Valencia (Spain) between November 2015 and May 
2016. Women in the immediate postpartum period 
(more than 27 weeks of gestation), between November 
2015 and May 2016 were included in the study. Women 
with impairments, language barriers or illiteracy which 
prevented completion of the questionnaires, or those who 
were under 18 years were excluded from enrolment.
Primary and secondary outcome measures HL level; 
influenza and pertussis immunisation rate; reasons for 
rejection of vaccination.
results 119 participants were included (mean age 
32.3±5.5 years, 52% primiparous, 95% full-term 
deliveries). A higher education level was associated with 
Short Assessment of Health Literacy for Spanish Adults 
_50 (adjusted R2=0.22, p=0.014) and Newest Vital Sign 
(adjusted R2=0.258, p=0.001) scores. Depending on the 
scale, 56%–85% of participants had adequate HL. 52% 
(62/119) and 94% (112/119) of women received influenza 
and pertussis immunisation, respectively. Women rejecting 
influenza vaccine had a higher HL level (measured by 
SALHSA_50 tool) than those accepting it (Kruskal-Wallis 
test p=0.022). 24% of women who declined influenza 
vaccination felt the vaccine was unnecessary, and 23% 
claimed to have insufficient information.
Conclusions Influenza vaccination rate was suboptimal in 
our study. Women with high HL were more likely to decline 
immunisation. Information from professionals needs to 
match patients' HL levels to reduce negative perceptions 
of vaccination.
bACkgrOund 
Despite its benefits, influenza vaccine 
coverage among pregnant women remains 
low.1 Some determinants associated with 
vaccination rejection include insufficient 
information by professionals and underesti-
mation of infection risks during pregnancy.2–4 
However, pregnancy is a risk factor for 
severe influenza, a main reason for hospital 
admission during gestation.5 The admin-
istration of influenza vaccine to pregnant 
women would protect immunised mothers 
and infants. As the safety of the vaccine is 
well established, its administration is recom-
mended during any trimester of gestation. 
Globally, influenza vaccination coverage is 
uneven, ranging from 15%–43% in Europe,6 
to 50% in the USA.7 In Spain, there are no 
published data on national influenza vacci-
nation coverage among pregnant women; 
however, our review in 2014–2015 reported 
vaccination rates of 40.5% in pregnant 
women in our health department.8
Vaccination against Bordetella pertussis is 
equally recommended to all pregnant women 
in Valencia (Spain) since January 2015 due to 
outbreaks of whooping cough.9 Women are 
offered immunisation on the third trimester, 
ideally between weeks 27 and 36 of gesta-
tion.6 As with influenza, maternal immunisa-
tion also benefits newborns.10 According to 
WHO, 195 000 children under 5 years died in 
2008 of whooping cough. More than 80% of 
deaths occurred in children younger than 6 
strengths and limitations of this study
 ► Validated health literacy screening tools were ad-
ministered to pregnant women to identify health lit-
eracy levels. Immunisation status was obtained from 
official vaccination records.
 ► Screening tools used in the study have been vali-
dated in Spanish-speaking populations in the USA 
but not Spain.
 ► Further research could focus on the development 
and use of pregnancy-specific scales.
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months of age. The number of whooping cough cases has 
increased since 2011 worldwide, including the European 
Union, and among children and young adults. In Spain, 
the case incidence has shifted from 739 cases in 2008 to 
3088 cases in 2011, a global rate of 6.73/100 000 habi-
tants/year for that year. Additionally, eight deaths in 2001 
were attributed to whooping cough.11 Of concern, there 
are currently no published data regarding whooping 
cough vaccination coverage among pregnant women in 
Spain. However, reports on the incidence of whooping 
cough in 2015 are available, indicating 17.99 cases per 
100 000 people, with provisional data for 2016 suggesting 
a marked decline in reported cases.12
Among the factors determining vaccination accep-
tance, health literacy (HL) refers to the knowledge and 
skills required when making health decisions.13 Essen-
tial HL skills include reading, writing, numeracy and 
searching for information.14 15 Inadequate HL has been 
associated with poor health outcomes including inad-
equate self-caring and preventive behaviours such as 
vaccination.16 Standardised tools for assessing HL are 
available, yet mostly in English17 and focused on US 
society. European researchers have developed question-
naires,18 and some tools (Short Assessment of Health 
Literacy for Spanish Adults; SAHLSA_50),19 20Newest 
Vital Sign (NVS)21–24 and Single Item Literacy Screener 
(SILS)25 have been validated in Spanish language but not 
for Spanish citizens.
Although vaccination is especially relevant for pregnant 
women and wider public health,26 no studies have been 
conducted in Spain exploring the relationship between 
HL and vaccine acceptance. We hypothesise that preg-
nant women with limited HL may be less likely to accept 
influenza and pertussis vaccinations in Valencia (Spain).
MethOds
study population and sampling criteria
We conducted a cross-sectional study in women who had 
given birth at La Ribera University Hospital (Hospital 
Universitario de La Ribera, HULR) in Valencia (Spain). 
The HULR serves a population of 250 000 citizens and is 
the only hospital providing maternity services to pregnant 
women in the area, with an annual average of 1600 births 
in the year when the study was carried out. The influenza 
and pertussis vaccine policy in the HULR mirrors the 
national policy, where vaccines are offered systematically, 
by community midwives and family doctors, to all women 
free of charge. In 2015, the influenza vaccination rate for 
the whole Valencian Community was 34.4%.
Immunisation campaign in Spain starts in October 
and concludes in March. In order to avoid seasonality, 
we included all women during the study period. Women 
in their immediate postpartum period (more than 27 
weeks of gestation), between November 2015 and May 
2016 were included in the study. We excluded women 
with impairments, language barriers or illiteracy. Illit-
erate women were excluded from the study due to their 
inability to complete the HL screening tools which were 
self-administered. Any help from the researchers would 
likely influence the results.27 Women younger than 
18 years were also excluded from taking part. Prior to 
data collection, written consent was obtained from each 
participant.
For recruitment, we systematically approached all 
women admitted to the maternity ward, every 4 days. To 
calculate the sample size, we used the SALHSA_50 tool 
as a reference with a cut-off score of 0–37 for inadequate 
literacy. Accepting an alpha risk of 0.05 and a beta risk 
of 0.2 in a bilateral contrast, with a common SD of 7.028 
and a loss to follow-up rate of 10%, we estimated that 102 
participants would be required.
Measurements
During the immediate postpartum (24–48 hours after 
delivery), we collected sociodemographic, obstetric vari-
ables and vaccination status through review of medical 
records, and HL from each woman through interview 
with the researcher in charge.
Participants’ HL was determined using three screening 
tools:
1. SALHSA_50: evaluates word recognition and reading 
comprehension through a 50-item tool. Quantitative 
scores classify individuals with ‘adequate’ (score: 38–50 
points) or ‘inadequate’ HL (score: 0–37 points). The 
tool has been validated for Hispanics in the USA.
2. NVS: evaluates reading and numeracy through six 
questions about the label of an ice-cream. The sum 
score (0–6 points) categorises individuals with high 
likelihood of limited literacy (score: 0–1 points), pos-
sibility of limited literacy (score: 2–3 points) and ade-
quate literacy (score: 4–6 points). It has been validated 
for the Hispanic population in the USA.23 It has high 
sensitivity, but it can misclassify people with adequate 
HL.29
3. SILS: it asks patients how often they need help when 
reading health instructions. The response is record-
ed on a 5-point Likert-type scale (1-never, 2-rarely, 
3-sometimes, 4-often and 5-always) and categorised as 
adequate or inadequate. Scores greater than 2 indicate 
some difficulty with reading materials.25
Regarding vaccination, we analysed: (1) influenza 
or pertussis vaccination status during pregnancy; (2) if 
vaccinated, health centre where vaccinated; (3) which 
healthcare provider recommended it and (4) if vaccina-
tion rejection, reasons for declining. Vaccination status 
was corroborated using the regional vaccination registry 
which records all vaccines received by patients.8
Other variables collected through review of medical 
records included: age, country of origin, civil status, occu-
pation, education, gestational age, parity, type of delivery, 
risk factors during pregnancy (without risk or low risk, 
pregestational or gestational diabetes, thyroid pathology, 
pre-eclampsia, twin pregnancy and assisted reproduction 
treatment).
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statistical analysis
In the univariate analysis, quantitative variables were 
described with means and SD or median and IQR, 
depending on the normality of their distribution. The 
Kolmogorov-Smirnov goodness-of-fit test was used to 
determine the normality of distributions. In the bivariate 
analysis, the χ2 test was used between the qualitative vari-
ables and the vaccination status. To compare the medical 
risk factors during pregnancy related to vaccination, OR 
with a 95% CI was calculated.
The non-parametric Mann-Whitney U test was used 
when the normality hypothesis was rejected when 
comparing independent samples with the categorised 
values of NVS and SAHLSA_50 and vaccination accep-
tance. To identify the variables explaining the level of 
HL according to each screening tool, a series of multi-
variate analyses were conducted. The multivariate lineal 
regression analysis (Wald statistic) was used regarding the 
explanatory covariates for the quantitative tools, NVS and 
SALHSA_50, and a multinomial model was constructed 
for the qualitative scale SILS. The level of statistical signif-
icance was set at 0.05. SPSS for Windows V.22.0 (IBM) was 
used for data analysis.
Patient and public involvement
Patients were not involved in the development of the 
research questions, the design of the study or the recruit-
ment of participants. Aggregated study results will be 
published on the website of the hospital, in suitable 
language.
results
Out of a total of 168 women who initially consented to 
be included in the study, 49 were excluded (29%) for 
the following reasons: 10 (20%) were breast feeding, 16 
(33%) had language barriers, 16 (33%) were busy, 4 (8%) 
were absent from their room and 3 (6%) were unwell. 
Therefore, the study sample comprised 119 participants 
(71%).
Table 1 presents the sociodemographic characteristics 
of participants. The mean age was 32.3±5.5 years, with 
29.5±5.4 as mean age for the first pregnancy. Fifty-two per 
cent (62) were primiparous. The mean gestational age at 
delivery was 39.1±1.5, with 95% (113) full-term deliveries 
(37–42 weeks).
The information and recommendation about vaccina-
tion came mainly from their midwives (94%), in 4% from 
the family doctor and 2% of women did not provide any 
information. As we wanted to be as sure as possible of the 
vaccination status of each participant, we validated the 
vaccination status reported by the participants with the 
immunisation status recorded in the official electronic 
immunisation registry. We corroborated that all women 
without immunisation recorded on the electronic record 
had not been vaccinated.
Regarding HL screening tools, the correlation 
between SAHLSA_50 and SILS was moderate, inversely 
proportional and significant (r=−0.251, p=0.007). The 
correlation between NVS and SAHLSA_50 was moderate 
and significant (r=0.349, p<0.001). The correlation 
between NVS and SILS was moderate, inversely propor-
tional and also significant (r=−0.307, p=0.001).
We also analysed the influence of participants’ educa-
tion on HL level and the scales of assessment. Higher 
education was directly related to higher SAHLSA_50 
(r=0.244, p<0.001) and NVS (r=0.366, p=0.002) scores. 
This relationship, however, was not present in the SILS 
scale.
Vaccination status
Seventeen per cent (20/62) of women had been vacci-
nated against influenza prior to pregnancy. Gestational 
influenza vaccination coverage was 52% (62/119). The 
vaccine was administered to 5% (4/62) of women by 
week 20, and to 16% (10/62) in the last weeks of gesta-
tion (more than 36 weeks). Concerning pertussis vaccine, 
94% (112/119) of women had it during pregnancy, with 
86% (96/112) vaccinated between weeks 27 and 32 of 
gestation. All women vaccinated against influenza were 
simultaneously vaccinated against whooping cough. 
There were no significant differences in sociodemo-
graphic or obstetric characteristics between pregnant 
vaccination status for influenza or pertussis (p=0.15 and 
p=0.35, respectively) (data not shown).
The reasons for rejection of women who were not vacci-
nated against influenza during pregnancy (57) are shown 
in figure 1. Twenty-five per cent (14/57) felt that the 
vaccine was unnecessary, 23% (13/57) claimed to have 
received insufficient information from health profes-
sionals and 14% (8/57) claimed that they had never been 
infected. The reasons reported by women declining vacci-
nation against pertussis were lack of information from 
health professionals (4/7; 57%) and lack of any prenatal 
care (3/7; 43%).
health literacy
In the NVS scale, we obtained an average score of 3.7±1.6 
with values between 0 and 6. These scores were categorised 
as inadequate (13% (16/119)), limited (30% (36/119)) 
and adequate HL (56% (67)). SAHLSA_50 scores were 
44.1±4.4 out of 50. Eighty-six per cent (102/119) of 
women had adequate HL levels (SAHLSA-50 score >37). 
According to the SILS, 24% (29/119) women replied 
‘never’ needing help when reading information, 29% 
(35/119) ‘rarely’, 27% (32/119) ‘sometimes’ and only 
6% (7/119) replied ‘often’ and 13% (16/119) replied 
‘always’.
To identify variables explaining HL levels according 
to each screening tool, multivariate analyses were 
conducted. Multivariate lineal regression was used 
regarding the explanatory covariates for quantitative 
tools, NVS and SALHSA_50. For these, the level of educa-
tion was found to be statistically significant (NVS (adjusted 
R2=0.258; p=0.001) and SALHSA_50 (adjusted R2=0.220; 
p=0.014)). A multinomial model was constructed for the 
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Table 1 Sociodemographic, clinical and obstetric characteristics of the sample by influenza vaccine status (n=119)
Total row Unvaccinated, n=57 Vaccinated, n=62
P  values*N N % N %
Civil status 
  With partner 48 20 35 28 45 0.458
  Married/civil partner 67 35 61 32 52
  Separated/divorced 4 2 4 2 3
Level of education
  Primary school 40 20 36 20 32 0.296
  Secondary school 42 19 33 23 37
  University 37 18 44 19 31
Employment status 
  I 13 9 16 4 6 0.083
  II 66 35 61 31 50
  III 2 0 0 2 3
  IV 1 0 0 1 2
  V 37 13 23 24 39
Country of Origin 
  Spain 104 51 89 53 85 0.261
  Another EU country 8 5 9 3 5
  Non-EU country 1 0 0 1 2
  Central-South America 6 1 2 5 8
Pertussis vaccine 
  Unvaccinated 7 7 12 0 0 0.269
  Vaccinated 112 50 88 62 100
Medical risk factors during pregnancy 
  None/low risk 92 45 79 47 76 0.570
  Pregestational/gestational 
diabetes
7 2 3 5 8
  Thyroid pathology 7 5 9 2 3
  Pre-eclampsia 1 0 0 1 2
  Twin pregnancy 3 1 2 2 3
  ART 9 4 7 5 8
NVS categories 
  Inadequate (0–1 points) 13 6 10 7 11 0.219
  Limited (2–3 points) 38 14 25 24 39
  Adequate (4–6 points) 68 37 65 31 50
SAHLSA categories 
  Inadequate (0–37 points) 17 6 10 11 18 0.261
  Adequate (38–50 points) 102 51 89 51 82
SILS categories 
  Never 29 13 23 16 26 0.947
  Rarely 34 17 30 17 27
  Sometimes 33 17 30 16 26
  Often 8 4 7 4 6
  Always 15 6 10 9 14
I, self-employed, higher professional or managerial employment; II, employee; III, student;  IV,  stay-at-home mother; V, unemployed. 
*Χ2.
ART, assisted-reproduction treatment; EU, European Union; NVS, Newest Vital Sign; SAHLSA, Short Assessment of Health Literacy 
for Spanish Adults; SILS, Single Item Literacy Screener.
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qualitative scale SILS, observing no statistically significant 
differences.
There were no differences in NVS and SILS scores 
between women who declined and those who accepted 
influenza vaccination (Mann-Whitney U test, p=0.320 and 
p=0.942, respectively). However, for SAHLSA_50 
(median=44.5; IQR=5.0 vs 45.0; IQR=5.5) the differ-
ences were statistically significant (Mann-Whitney U test, 
p=0.019) (figure 2).
Later, scores from the quantitative HL screening 
tools (NVS, SALHSA_50) were distributed in quartiles 
(figure 3). For the NVS scale, we found no statistically 
significant different between women who had accepted 
or declined vaccination (p=0.532). However, such differ-
ence was seen when using the SALHSA_50 tool (Krus-
kal-Wallis test, p=0.022). The median number of women 
vaccinated in the bottom quartile was 8 (95% CI 7.0 to 
9.0) versus 24 (95% CI 23.0 to 25.0) in the top quartile.
We were interested in examining the characteristics of 
the women who were excluded from the study (49). We 
conducted an analysis of missing values for the three HL 
screening tools using the multiple imputation chained 
equations method.30 Again, for the NVS scale, we found 
no statistically significant difference between women 
who had accepted or declined vaccination (p=0.372) 
Figure 2 Relationship between acceptance of influenza 
vaccination and SAHLSA_50 scale (n=119). SAHLSA, Short 
Assessment of Health Literacy for Spanish Adults.
Figure 3 Relationship between acceptance of influenza 
vaccination and SAHLSA_50 scale distribution by quartiles 
(n=119). SAHLSA, Short Assessment of Health Literacy for 
Spanish Adults. 
Figure 1 Reasons given by participants to decline influenza vaccination.
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and, instead, such difference was seen when using the 
SALHSA_50 tool (Kruskal-Wallis test, p=0.003). The 
median number of women vaccinated in the bottom 
quartile was 11 (95% CI 9.0 to 12.0) vs 28 (95% CI 27.0 to 
29.0) in the top quartile.
Regarding the NVS, scores between pertussis-vaccinated 
and unvaccinated women were similar (median=4.0; 
IQR=0.0 vs median=4.0; IQR=2.75), like the SAHLSA_50 
scale (median=45.0; IQR=0.0 vs median=45.0; IQR=5.0). 
We also did not find any difference with the results from 
the SILS tool.
disCussiOn
Vaccination is an essential public health intervention. We 
focused on pregnant women, an especially vulnerable 
population, and studied the acceptance of two vaccines 
underused in our community.8 Few studies evaluating HL 
and vaccination have been conducted thus far and, up to 
now, none had focused on pregnant women.
In our study, influenza vaccination did not reach 
recommended levels although coverage slightly exceeded 
Australian31 but not US rates.32 In Valencia, coverage 
has progressively improved from 2011 (8.5%) to 2015 
(34.4%).8 Regarding pertussis, the 97% vaccination rate 
improves on Belgian (39%)33 or UK (70%)6 rates. The 
disparity between pertussis and influenza immunisation 
rates has not been previously addressed in detail.6 We 
believe that in our setting, fear to pertussis—perhaps 
influenced by mass media34 and fuelled by the increasing 
number of cases—could explain such high vaccination 
prevalence. Indeed, the pertussis vaccination programme 
was commenced following a surge in the number of cases 
and deaths. Clinicians may have therefore been keener to 
ensure that pregnant women got vaccinated and may have 
framed their advice more assertively. On the other hand, 
the disinterest from health professionals in providing 
information about influenza vaccination together with 
maternal perceptions that influenza vaccine was unneces-
sary were the most frequently cited causes of vaccine rejec-
tion, in agreement with prior studies.5–8 35 This position 
obviously ignores the benefits of acquired immunity for 
the newborn which could reduce perinatal infections.36
We found that NVS classified 58% of participants with 
adequate HL. However, this figure increased up to 89% 
if SAHLSA_50 was used. Currently, there are no publica-
tions comparing both scales simultaneously in the same 
population. Such discrepancy between screening tools 
could be of much relevance as, of the tools pragmatically 
chosen for our research, only SALHSA_50 was predic-
tive of vaccination in pregnant women. However, women 
with high SALHSA_50 scores were more likely to decline 
influenza vaccination, perhaps due to preconceived 
ideas; it might also be that women with high HL have 
more abilities to look for information on the internet 
or other sources and construct a narrative that supports 
such preconceptions, leading to declining this vaccina-
tion.37 Such narratives would also not be challenged if 
professionals fail to adequately inform them or focus their 
persuasion solely on rational, data-based reasons instead 
of complementing such evidence with other emotional 
and behavioural aspects.36 38 39 These results diverge from 
current evidence4 in this group of women possibly highly 
involved in their healthcare, as already explored.40
As perhaps expected, HL screening results were directly 
related to the education of participants and thus, a higher 
level of education was associated with higher HL. Inter-
estingly, other authors have reported that a higher level 
of education is associated with higher rates of vaccine 
rejection and hesitation.35 41 In fact, it would appear that 
the emerging relationship between HL and vaccination 
described by those authors may be represented as an 
‘inverted U’ shape’ (ie, high and low HL levels equally 
associated with low vaccination).
The analysis of missing values would help resolve 
some of the challenges originated from the incomplete 
responses. If cases with missing data were to be systemat-
ically different to cases with complete information, then 
results could be equivocal.30 In our case, however, the anal-
ysis of missing values did not produce different results to 
the original analysis conducted without imputed values.
Our study presents limitations. Although there are 
approximately 51 HL tools available,17 experiences in 
Spain with these instruments have been few and limited 
to the Health Literacy Survey—European Union42 or the 
eHealth Literacy43 tools. In addition, none of these tools 
have been validated in Spain, yet they have been so in 
Spanish-speaking US populations. Moreover, as there are 
no scales specifically focused on pregnant women, our 
questionnaire selection was eminently pragmatic and 
based on ease of use (SILS), robustness (SAHLSA_50) 
and reliability (NVS). Additionally, the routine use of HL 
screening tools in clinical practice remains nevertheless 
controversial, as such routine screening has shown no 
benefits yet could have undesirable effects for patients.44
Decisions related to vaccination may be influenced by 
the information provided, the communication approaches 
and attitudes of by health professionals.35 36 Since there 
is currently no standardised approach to determine the 
abilities that pregnant women have to make effective use 
of the information provided, we hypothesise that infor-
mation offered to each woman will be more or less similar 
and, therefore, women with low HL may be more likely to 
make suboptimal decisions because of such deficit. Logi-
cally, this does not consider efforts that professionals may 
make to compensate for any difficulties in understanding. 
Although exploring such efforts was outside the remit of 
our work, it would be interesting to investigate this aspect 
in future studies, together with any supporting materials 
used by professionals.
COnClusiOn
Vaccination is an essential public health measure, and 
pregnant women can particularly benefit from this inter-
vention. Identifying determinants of vaccination such 
7Castro-Sánchez E, et al. BMJ Open 2018;8:e022132. doi:10.1136/bmjopen-2018-022132
Open access
as HL would facilitate an adequate use of resources to 
encourage shared decision-making, ultimately resulting 
in optimal vaccination rates. Our findings suggesting a 
relation between high HL and rejection of vaccination 
encourage further research to identify and describe the 
factors involved in such relation and implement miti-
gating initiatives.
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